Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06551337
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
Vitamin D Replacement in Bronchiectasis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Prospective Clinical Study on Vitamin D Replacement in Bronchiectasis - A Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study seeks to address the limitations in previous related studies on vitamin D replacement and bronchiectasis exacerbation occurrence through a self-controlled pilot study The investigators aim to investigate whether vitamin D replacement in bronchiectasis patients with vitamin D deficiency can reduce hospitalized bronchiectasis exacerbation occurrence Patients who participated in the prior study entitled Prospective clinical study on serum 25-hydroxyvitamin D 25-OH D level and risk of bronchiectasis exacerbation UW 22-317 will be invited for participation during regular clinic follow-up and management in Queen Mary Hospital If participants are willing to join the further research participants will be recruited in this self-controlled study There are some differences from usual management to non-CF bronchiectasis subjects The study subjects would be checked for their blood 25-hydroxyvitamin-D level during the study period The non-CF bronchiectasis subjects with Vitamin D deficiency would be given 1000 IU and 2000 IU if needed The investigators aim to correct their Vitamin D deficiency completely aiming at blood 25-hydroxyvitamin-D level 50 ie treat to target The dose depends on the level of Vitamin D after replacement If blood 25-hydroxyvitamin-D level is 50 or above then 1000 IU is suffice If blood 25-hydroxyvitamin-D level is still below 50 the investigators will increase to 2000 IU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None